Cost-Effectiveness of Oral Nutritional Supplements in Malnourished or at Risk of Disease-Related Malnutrition Cancer Patients in North Macedonia
ClinicoEconomics and Outcomes Research · 2025-03 · Volume 17 · 265-276
DOI: 10.2147/ceor.s504094 ↗Kurz gefasst
Fachartikel in der Zeitschrift ClinicoEconomics and Outcomes Research, 2025-03. Verfasst von Aleksandra Kapedanovska Nestorovska und 1 weiteren Autor:innen. Beteiligte Einrichtung: Center for Medication Therapy Management, Faculty of Pharmacy, Ss. Cyril and Methodius University in Skopje, Skopje, Republic of North Macedonia. Die Arbeit wurde bisher 6-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Themen: Onkologische Pflege, Mangelernährung
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Center for Medication Therapy Management, Faculty of Pharmacy, Ss. Cyril and Methodius University in Skopje, Skopje, Republic of North Macedonia.
ORCID-Profile: Aleksandra Kapedanovska Nestorovska
Zitieren
APA
Kapedanovska Nestorovska, A., & Sterjev, Z. (2025). Cost-Effectiveness of Oral Nutritional Supplements in Malnourished or at Risk of Disease-Related Malnutrition Cancer Patients in North Macedonia. ClinicoEconomics and Outcomes Research, Volume 17, 265-276. https://doi.org/10.2147/ceor.s504094
Vancouver
Kapedanovska Nestorovska A, Sterjev Z. Cost-Effectiveness of Oral Nutritional Supplements in Malnourished or at Risk of Disease-Related Malnutrition Cancer Patients in North Macedonia. ClinicoEconomics and Outcomes Research. 2025;Volume 17:265-276. doi:10.2147/ceor.s504094
BibTeX
@article{KapedanovskaNestorovska2025,
author = {Kapedanovska Nestorovska, Aleksandra and Sterjev, Zoran},
title = {Cost-Effectiveness of Oral Nutritional Supplements in Malnourished or at Risk of Disease-Related Malnutrition Cancer Patients in North Macedonia},
journal = {ClinicoEconomics and Outcomes Research},
year = {2025},
volume = {Volume 17},
pages = {265--276},
doi = {10.2147/ceor.s504094}
}
EUVIMED